Abstract:Mitochondria play a crucial role in the progression of nasopharyngeal carcinoma (NPC). YME1L, a member of the AAA ATPase family, is a key regulator of mitochondrial function and has been implicated in various cellular processes and diseases. This study investigates the expression and functional significance of YME1L in NPC. YME1L exhibits significant upregulation in NPC tissues from patients and across various primary human NPC cells, while its expression remains relatively low in adjacent normal tissues and primary nasal epithelial cells. Employing genetic silencing through the shRNA strategy or knockout (KO) via the CRISPR-sgRNA method, we demonstrated that YME1L depletion disrupted mitochondrial function, leading to mitochondrial depolarization, reactive oxygen species (ROS) generation, lipid peroxidation, and ATP reduction within primary NPC cells. Additionally, YME1L silencing or KO substantially impeded cell viability, proliferation, cell cycle progression, and migratory capabilities, concomitant with an augmentation of Caspase-apoptosis activation in primary NPC cells. Conversely, ectopic YME1L expression conferred pro-tumorigenic attributes, enhancing ATP production and bolstering NPC cell proliferation and migration. Moreover, our findings illuminate the pivotal role of YME1L in Akt-mTOR activation within NPC cells, with Akt-S6K phosphorylation exhibiting a significant decline upon YME1L depletion but enhancement upon YME1L overexpression. In YME1L-silenced primary NPC cells, the introduction of a constitutively-active Akt1 mutant (caAkt1, at S473D) restored Akt-S6K phosphorylation, effectively ameliorating the inhibitory effects imposed by YME1L shRNA. In vivo studies revealed that intratumoral administration of YME1L-shRNA-expressing adeno-associated virus (AAV) curtailed subcutaneous NPC xenograft growth in nude mice. Furthermore, YME1L downregulation, concurrent with mitochondrial dysfunction and ATP reduction, oxidative injury, Akt-mTOR inactivation, and apoptosis induction were evident within YME1L-silenced NPC xenograft tissues. Collectively, these findings shed light on the notable pro-tumorigenic role by overexpressed YME1L in NPC, with a plausible mechanism involving the promotion of Akt-mTOR activation.

YPEL3 Suppresses Epithelial–mesenchymal Transition and Metastasis of Nasopharyngeal Carcinoma Cells Through the Wnt/β-catenin Signaling Pathway

As an Independent Unfavorable Prognostic Factor, IL-8 Promotes Metastasis of Nasopharyngeal Carcinoma Through Induction of Epithelial–mesenchymal Transition and Activation of AKT Signaling

YBX3 Mediates the Metastasis of Nasopharyngeal Carcinoma Via PI3K/AKT Signaling

LncRNA EPB41L4A-AS2 Represses Nasopharyngeal Carcinoma Metastasis by Binding to YBX1 in the Nucleus and Sponging MiR-107 in the Cytoplasm

The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling

ZNF582 hypermethylation promotes metastasis of nasopharyngeal carcinoma by regulating the transcription of adhesion molecules Nectin‐3 and NRXN3

Yin Yang 1 Suppresses Tumor Invasion and Metastasis in Nasopharyngeal Carcinoma by Negatively Regulating Eif4e Transcriptional Activity and Expression.

MicroRNA-483-5p Predicts Poor Prognosis and Promotes Cancer Metastasis by Targeting EGR3 in Nasopharyngeal Carcinoma

Upregulated METTL3 in Nasopharyngeal Carcinoma Enhances the Motility of Cancer Cells

The E3 ligase NEURL3 suppresses epithelial-mesenchymal transition and metastasis in nasopharyngeal carcinoma by promoting vimentin degradation

EZH2-DNMT1-mediated Epigenetic Silencing of Mir-142-3p Promotes Metastasis Through Targeting ZEB2 in Nasopharyngeal Carcinoma

Targeting the PLUNC-NLRP3 inflammasome axis could inhibit nasopharyngeal carcinoma lung metastasis

Expression and functional implications of YME1L in nasopharyngeal carcinoma

CDC42-interacting Protein 4 Promotes Metastasis of Nasopharyngeal Carcinoma by Mediating Invadopodia Formation and Activating EGFR Signaling

EGFR-PKM2 Signaling Promotes the Metastatic Potential of Nasopharyngeal Carcinoma Through Induction of FOSL1 and ANTXR2

Long non-coding RNA NEAT1 regulates epithelial membrane protein 2 expression to repress nasopharyngeal carcinoma migration and irradiation-resistance through miR-101-3p as a competing endogenous RNA mechanism

Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway

Ott_a_233435 11271..11280

LncRNA FOXP4-AS1 Silencing Inhibits Metastasis and Epithelial–mesenchymal Transition in Nasopharyngeal Carcinoma Via Mir-136-5p/mapk1

MicroRNA-432 Suppresses Invasion and Migration Via E2F3 in Nasopharyngeal Carcinoma

PLUNC inhibits invasion and metastasis in nasopharyngeal carcinoma by inhibiting NLRP3 inflammasome activation